Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 12, 2023

SELL
$9.59 - $11.35 $23,102 - $27,342
-2,409 Reduced 99.18%
20 $0
Q2 2023

Jul 24, 2023

BUY
$9.02 - $10.29 $21,909 - $24,994
2,429 New
2,429 $24,000
Q2 2022

Jul 25, 2022

SELL
$9.95 - $12.27 $238 - $294
-24 Reduced 19.35%
100 $1,000
Q2 2021

Jul 26, 2021

SELL
$12.97 - $16.15 $1,167 - $1,453
-90 Reduced 42.06%
124 $2,000
Q1 2021

Apr 20, 2021

SELL
$13.59 - $18.54 $2,704 - $3,689
-199 Reduced 48.18%
214 $3,000
Q4 2020

Jan 25, 2021

BUY
$14.3 - $18.74 $5,905 - $7,739
413 New
413 $8,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Toth Financial Advisory Corp Portfolio

Follow Toth Financial Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Toth Financial Advisory Corp with notifications on news.